BATTLE Program: ZD6474 in Previously Treated Subjects With NSCLC
Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
Primary Objective:
- To determine the 8 week progression-free survival rate (i.e. disease control rate) in
patients with advanced NSCLC who have failed at least one prior chemotherapy regimen.
Secondary Objectives:
- Determine the overall response rate
- Determine the overall survival
- Determine the time to disease progression
- Assess the safety/toxicity of the study treatment
- Assess biomarker modulation in the tumor tissue and serum samples from the treatment
- Assess plasma and intra-tumor concentrations of study treatment